In colon cancer, demethyleneberberine could induce apoptosis and effectively inhibit TGF-β/Smad-induced epidermal mesenchymal transition in HCT-116, exhibiting a more effective inhibition ability on the colon cancer cell proliferation than BBR [74]. This evidence concerns the gene TGFB1 and malignant colon neoplasm.